ARTICLE | Clinical News
Sulfasim: Filed IND for a Phase I/II trial
March 13, 1995 8:00 AM UTC
Cortech Inc. (CRTQ), Denver Product: Sulfasim, blocker of immune system recognition of the antimicrobial sulfamethoxazole, used in AIDS to prevent or treat Pneumocystis carenii pneumonia Indication: P...